Tag: astrazeneca

November 12, 2019

Aravive and AstreZeneca Begin Phase 1/2 Study of AVB-500

The Phase 1/2 clinical trial of AVB-500 is being done in combination with durvalumab in patients with ovarian cancer.
October 8, 2019

5 Top NASDAQ Pharma Stocks Year-to-Date

With Q4 in full swing, it's time to reflect on the top-performing NASDAQ pharma stocks year-to-date.
October 2, 2019

GlaxoSmithKline Files NDA for Inhaler to Treat Asthma

The company's inhaler therapy, Trelegy Ellipta, has already been approved in the US for chronic obstructive pulmonary disease.
August 29, 2019

AstraZeneca’s Lupus Drug Finally Meets Endpoints in Phase 3 Trial

The victory comes almost exactly a year after AstraZeneca's lupus treatment didn't meet its primary endpoints in a different trial.
July 4, 2019

5 Top Biotech Stocks by Market Cap

What are the biggest names in biotechnology? We count down the five top biotech stocks based on market cap and...
April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
March 26, 2019

7 Potential Blockbuster Drugs Investors Should Watch for in 2019

A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...